QSAM Biosciences, Inc.
QSAM Biosciences, Inc., headquartered in the United States, is a pioneering biotechnology firm focused on developing innovative therapies for cancer treatment. Founded in 2020, the company has quickly established itself in the biopharmaceutical industry, particularly in the areas of drug development and precision medicine. With a commitment to advancing cancer care, QSAM Biosciences is known for its unique approach to targeting tumours through its proprietary radiopharmaceuticals. The company’s core products aim to enhance the efficacy of existing treatments while minimising side effects, setting it apart in a competitive market. Recognised for its rapid growth and strategic partnerships, QSAM Biosciences continues to make significant strides in oncology, positioning itself as a leader in the quest for more effective cancer therapies.
DitchCarbon Score
How does QSAM Biosciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
QSAM Biosciences, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
QSAM Biosciences, Inc.'s reported carbon emissions
QSAM Biosciences, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. However, it is important to note that QSAM Biosciences, Inc. is a current subsidiary of Telix Pharmaceuticals Limited. As such, any potential climate initiatives or emissions data may be influenced by the parent company's strategies and commitments. The emissions data and climate strategies from Telix Pharmaceuticals Limited could provide insights into QSAM's environmental impact, although specific figures or targets have not been disclosed. In summary, while QSAM Biosciences, Inc. does not currently report emissions or reduction targets, its affiliation with Telix Pharmaceuticals Limited may play a role in shaping its future climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
QSAM Biosciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
